LoginSignup
Johnson&Johnson logo

Johnson&Johnson

Stock
Stock
Ticker: JNJ
JNJ

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Johnson&Johnson has so far distributed $3.98 in 2026. The next dividend will be paid on 09.12.2026

$1.608

CHART BY

Frequently asked questions

The market capitalization of Johnson&Johnson is $641.80B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Johnson&Johnson is 30.87. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Johnson&Johnson's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $8.628. EPS indicates the company's profitability on a per-share basis.
Currently, 27 analysts cover Johnson&Johnson's stock, with a consensus target price of $282.10. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Johnson&Johnson reported a revenue of $97.94B.
Johnson&Johnson's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $34.18B. EBITDA measures the company's overall financial performance.
Johnson&Johnson has a free cash flow of $22.24B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Johnson&Johnson employs approximately 140,800 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Johnson&Johnson is 2.41B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$641.80B
EPS (TTM) 
$8.628
Free Float 
2.41B
P/E ratio (TTM) 
30.87
Revenue (TTM) 
$97.94B
EBITDA (TTM) 
$34.18B
Free Cashflow (TTM) 
$22.24B

Pricing

1D span
$266.17$269.18
52W span
$173.39$281.00

Analyst Ratings

The price target is $282.10 and the stock is covered by 27 analysts.

Buy

19

Hold

7

Sell

1

Information

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Employees
140,800
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
JNJ

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin